PBM Safe Harbor Compliance May Cause “Difficulty” With Manufacturers
Executive Summary
The HHS Inspector General's compliance guide for the pharmaceutical industry could cause friction between manufacturers and pharmacy benefit management companies over conformity with safe harbors
You may also be interested in...
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
The Senate Finance Medicare drug coverage bill includes language dictating that beneficiaries cannot be forced to pay a higher copay for a non-formulary product if it is determined to be medically necessary
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
The Senate Finance Medicare drug coverage bill includes language dictating that beneficiaries cannot be forced to pay a higher copay for a non-formulary product if it is determined to be medically necessary
PBM Practice Standards May Be Defined By Settlements, Not IG Guide
The first PBM to settle a Justice Department investigation of its business practices could emerge with a competitive advantage in the sector, Health Strategies Consultancy Managing Director Dan Mendelson told the Schwab Washington Research Group conference May 14